Guo Yang

ORCID: 0000-0003-1601-440X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroendocrine Tumor Research Advances
  • Urinary and Genital Oncology Studies
  • Cancer-related molecular mechanisms research
  • Cancer, Lipids, and Metabolism
  • RNA Research and Splicing
  • RNA and protein synthesis mechanisms
  • Autophagy in Disease and Therapy
  • PI3K/AKT/mTOR signaling in cancer
  • Cancer, Hypoxia, and Metabolism
  • Estrogen and related hormone effects
  • Prostate Cancer Treatment and Research
  • Gestational Trophoblastic Disease Studies
  • Lung Cancer Research Studies
  • Metabolomics and Mass Spectrometry Studies
  • DNA Repair Mechanisms
  • RNA modifications and cancer

The Affiliated Yongchuan Hospital of Chongqing Medical University
2022-2025

Chongqing Medical University
2022-2025

Hangzhou Medical College
2024

Zhejiang Provincial People's Hospital
2024

Progression to castration resistance is the leading cause of death in prostate cancer patients. Long non-coding RNAs (lncRNAs) have recently become a focal point regulation development. However, few lncRNAs associated with castration-resistant (CRPC) been reported. Firstly, we explore CRPC by RNA sequencing and validated using quantitative polymerase chain reaction (qRT-PCR) fluorescence situ hybridization (RNA-FISH). The clinical significance FLJ was evaluated collected cohort. Functional...

10.1186/s12967-025-06294-9 article EN cc-by-nc-nd Journal of Translational Medicine 2025-03-03

Prostate cancer (PCa) is a common malignant in elderly males Western countries. Whole-genome sequencing confirmed that long non-coding RNAs (lncRNAs) are frequently altered castration-resistant prostate (CRPC) and promote drug resistance to therapy. Therefore, elucidating the prospective role of lncRNAs PCa oncogenesis progression remarkable clinical significance. In this study, gene expression tissues was determined using RNA-sequencing datasets, diagnostic prognostic values CRPC were...

10.1016/j.ygeno.2023.110599 article EN cc-by-nc-nd Genomics 2023-03-01

Abstract Background:Neuroendocrine carcinoma mainly occurs in the lung and gastrointestinal tract, rarely urinary tract. The proportion of neuroendocrine carcinomas was less than 0.05 % [2] malignant tumors. most common location system is bladder. Fewer occur ureter Case presentation: A 62 years old woman presented with right ureteral obstruction due to mass. patient began chemotherapy 2 weeks after surgery. During 14-month follow-up, received 6 courses etoposide Carbopol chemotherapy,...

10.21203/rs.3.rs-2246068/v2 preprint EN cc-by Research Square (Research Square) 2023-01-18

Abstract Background : Neuroendocrine carcinoma mainly occurs in the lung and gastrointestinal tract, rarely urinary tract. The proportion of neuroendocrine carcinomas was less than 0.05 % [2] malignant tumors. most common location system is bladder. Fewer occur ureter Case presentation: A 62 years old woman presented with right ureteral obstruction due to mass. patient began chemotherapy 2 weeks after surgery. During 14-month follow-up, received 6 courses etoposide Carbopol chemotherapy,...

10.21203/rs.3.rs-2246068/v1 preprint EN cc-by Research Square (Research Square) 2022-11-15
Coming Soon ...